Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Intangibles (2023 - 2025)

Envoy Medical's Intangibles history spans 3 years, with the latest figure at $7.5 million for Q2 2025.

  • For Q2 2025, Intangibles changed N/A year-over-year to $7.5 million; the TTM value through Jun 2025 reached $7.5 million, changed N/A, while the annual FY2023 figure was $10.0 million, N/A changed from the prior year.
  • Intangibles for Q2 2025 was $7.5 million at Envoy Medical, roughly flat from $7.5 million in the prior quarter.
  • Across five years, Intangibles topped out at $10.0 million in Q3 2023 and bottomed at $7.5 million in Q3 2024.
  • The 3-year median for Intangibles is $7.5 million (2024), against an average of $8.5 million.
  • The largest YoY upside for Intangibles was 25.0% in 2024 against a maximum downside of 25.0% in 2024.
  • A 3-year view of Intangibles shows it stood at $10.0 million in 2023, then fell by 25.0% to $7.5 million in 2024, then changed by 0.0% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Intangibles are $7.5 million (Q2 2025), $7.5 million (Q1 2025), and $7.5 million (Q3 2024).